Alyeska Investment Group
AGN

Alyeska Investment Group’s Allergan plc AGN Stock Holding History

Alyeska Investment Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-317,564
Closed -$53.2M – 550
2019
Q2 		$53.2M Buy
+317,564
New +$44M 0.69% 42
2017
Q1 		– Sell
-11,957
Closed -$2.51M – 585
2016
Q4 		$2.51M Buy
11,957
+8,724
+270% +$1.81M 0.02% 379
2016
Q3 		$745K Buy
+3,233
New +$790K 0.01% 420
2016
Q2 		– Sell
-450,000
Closed -$121M – 529
2016
Q1 		$121M Buy
+450,000
New +$129M 1.11% 10
2015
Q2 		– Sell
-26,170
Closed -$7.79M – 599
2015
Q1 		$7.79M Buy
+26,170
New +$7.46M 0.11% 249
2014
Q4 		– Sell
-119,577
Closed -$28.9M – 558
2014
Q3 		$28.9M Buy
+119,577
New +$26.8M 0.59% 40
2013
Q3 		– Sell
-47,000
Closed -$5.93M – 367
2013
Q2 		$5.93M Buy
+47,000
New +$5.32M 0.29% 113

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alyeska Investment Group's AGN Position: Q3 2019 in Review

Alyeska Investment Group sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 317,564 shares — an estimated $53.2M sold.

Alyeska Investment Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $121M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Alyeska Investment Group reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 317,564 Allergan plc shares in Q3 2019, an estimated $53.2M.
  • Alyeska Investment Group first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • Alyeska Investment Group's Allergan plc position peaked at $121M in Q1 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.